Clinical trial
A Study of E7389 in Advanced/Metastatic Breast Cancer Patients
NCT00097721 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00097721 |
|---|---|
| Title | A Study of E7389 in Advanced/Metastatic Breast Cancer Patients |
| Official title | A Phase II Open Label Study of E7389 (Halichondrin B Analog) in Patients With Advanced/Metastatic Breast Cancer Previously Treated With Chemotherapy Including An Anthracycline and A Taxane |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | E7389 |
| Enrollment | 104 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 30, 2004 |
| Last update posted | Apr 22, 2013 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: